(Q44257114)

1 December 2017

title

Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. (English)

1 reference

1 December 2017

0 references

0 references

R O'Donovan

1

1 reference

1 December 2017

D Baldwin

2

1 reference

1 December 2017

M Hammer

3

1 reference

1 December 2017

C Moniz

4

1 reference

1 December 2017

V Parsons

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

1 December 2017

1 reference

1 December 2017

volume

1

1 reference

1 December 2017

issue

8486

1 reference

1 December 2017

page(s)

880-882

1 reference

Phosphorus excretion in renal failure

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Control of secondary hyperparathyroidism during long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Aluminium in Bone from Patients with Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

The dialysis encephalopathy syndrome. Possible aluminum intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Aluminium-induced anaemia in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

HYPERMAGNESEMIA IN RENAL FAILURE. ETIOLOGY AND TOXIC MANIFESTATIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

The effect of dialysate magnesium on plasma and erythrocyte magnesium and potassium concentrations during maintenance haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

The long-term effect of lowering dialysate magnesium on circulating parathyroid hormone in patients on regular haemodialysis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Determination of aluminium in serum: findings of an external quality assessment scheme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Estimation of Biologically Active Intact Parathyroid Hormone in Normal and Hyperparathyroid Sera by Sequential N-terminal Immunoextraction and Midregion Radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Hypomagnesaemia: studies of parathyroid hormone secretion and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Total-body magnesium excess in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

Re: the use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990987-6

7 January 2021

10.1016/S0140-6736(86)90987-6

Identifiers

DOI

1 reference

1 December 2017

1 reference